<DOC>
	<DOCNO>NCT00445497</DOCNO>
	<brief_summary>RATIONALE : Finishing antibiotic regimen home may effective receive hospital . It yet know whether early hospital discharge effective standard inpatient care cancer patient receive antibiotic febrile neutropenia . PURPOSE : This randomized phase III trial study early hospital discharge compare standard inpatient care cancer patient receive antibiotic febrile neutropenia .</brief_summary>
	<brief_title>Early Hospital Discharge Standard Inpatient Care Cancer Patients Receiving Antibiotics Febrile Neutropenia</brief_title>
	<detailed_description>OBJECTIVES : - Identify cancer patient low-risk inpatient meet criterion early discharge ( i.e. , symptomatic improvement temperature ≤ 37.8°C ) receive oral antibiotic febrile neutropenia . OUTLINE : This randomize , prospective , multicenter study . Patients stratify disease type ( lymphoma v solid tumor ) , duration registration ( &lt; 48 hour vs &gt; 48 hour ) , participate center . Patients receive oral amoxicillin-clavulanate potassium 3 time daily oral ciprofloxacin twice daily admission hospital . Treatment continue 7 day absence clinical deterioration unacceptable toxicity . Patients assess inpatient ≥ 24 72 hour first antibiotic dose . Patients show clear response ( i.e. , symptomatic improvement irrespective neutrophil recovery , temperature ≤ 37.8 C 24 hour ) continue meet study eligibility criterion randomize 1 2 arm . - Arm I ( early discharge ) : Patients discharge home instruct remain daily contact hospital staff report temperature symptoms completion oral antibiotic regimen . - Arm II ( standard management ) : Patients continue antibiotic course hospital discharge accord local guideline follow additional criterion : subjective improvement , afebrile ( ≤ 37°C 24 hour ) , absolute neutrophil count ≥ 500/mm³ rise . Patients arm complete daily diary document daily temperature reading , symptom , toxicity . Patients also complete Health Questionnaire Cancer Worries Inventory Booklet baseline , hospital immediately randomization , completion oral antibiotic resolution neutropenic febrile episode . Peer Reviewed Funded Endorsed Cancer Research UK PROJECTED ACCRUAL : A total 400 patient accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Intestinal Neoplasms</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis solid tumor lymphoma AND meet follow criterion : Lowrisk patient , define Multinational Association Supportive Care Cancer prognostic index score ≥ 21 Presents neutropenic fever define follow : Absolute neutrophil count ≤ 500/mm³ OR &lt; 1,000/mm³ anticipate fall ≤ 500/mm³ within 24 hour study entry Temperature ≥ 38.5°C single measurement ≥ 38.0°C &gt; 1 occasion ( one could measure patient prior admission ) ≥ 1 hour apart Undergoing concurrent cytotoxic chemotherapy treatment solid tumor lymphoma No leukemia PATIENT CHARACTERISTICS : Compliant appropriate early discharge Able read thermometer ( patient caregiver ) Able tolerate oral medication Must responsible adult caregiver eligible early discharge No known allergy oral antibiotic penicillin No requirement IV fluid support No central venous catheterassociated infection evidence infection amenable treatment study antibiotics No neutropenic fever high risk complication No associate comorbidity require hospitalization management No known HIV positivity PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior participation study neutropenic episode No prior bone marrow transplantation peripheral blood stem cell transplantation No prior treatment leukemia More 72 hour since prior antibiotic , include prophylactic antibiotic Prophylactic septrin ( pneumocystis ) , acyclovir , antifungal allow No concurrent granulocyte colonystimulating factor therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>anaplastic large cell lymphoma</keyword>
	<keyword>angioimmunoblastic T-cell lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>intraocular lymphoma</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>primary central nervous system non-Hodgkin lymphoma</keyword>
	<keyword>primary central nervous system Hodgkin lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent mycosis fungoides/Sezary syndrome</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>small intestine lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage III adult Hodgkin lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult lymphoblastic lymphoma</keyword>
	<keyword>stage III adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage III cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage III grade 1 follicular lymphoma</keyword>
	<keyword>stage III grade 2 follicular lymphoma</keyword>
	<keyword>stage III grade 3 follicular lymphoma</keyword>
	<keyword>stage III mantle cell lymphoma</keyword>
	<keyword>stage III marginal zone lymphoma</keyword>
	<keyword>stage III mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage III small lymphocytic lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult Hodgkin lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage IV cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>stage IV marginal zone lymphoma</keyword>
	<keyword>stage IV mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage IV small lymphocytic lymphoma</keyword>
	<keyword>Waldenström macroglobulinemia</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>neutropenia</keyword>
	<keyword>stage I adult Burkitt lymphoma</keyword>
	<keyword>stage I adult diffuse large cell lymphoma</keyword>
	<keyword>stage I adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage I adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage I adult Hodgkin lymphoma</keyword>
	<keyword>stage I adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage I adult lymphoblastic lymphoma</keyword>
	<keyword>stage II adult Hodgkin lymphoma</keyword>
	<keyword>stage I mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage II mycosis fungoides/Sezary syndrome</keyword>
	<keyword>stage I cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage II cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>contiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>contiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>contiguous stage II adult lymphoblastic lymphoma</keyword>
	<keyword>contiguous stage II grade 1 follicular lymphoma</keyword>
	<keyword>contiguous stage II grade 2 follicular lymphoma</keyword>
	<keyword>contiguous stage II grade 3 follicular lymphoma</keyword>
	<keyword>contiguous stage II mantle cell lymphoma</keyword>
	<keyword>contiguous stage II marginal zone lymphoma</keyword>
	<keyword>contiguous stage II small lymphocytic lymphoma</keyword>
	<keyword>noncontiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse mixed cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse small cleave cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult lymphoblastic lymphoma</keyword>
	<keyword>noncontiguous stage II grade 1 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 2 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II grade 3 follicular lymphoma</keyword>
	<keyword>noncontiguous stage II mantle cell lymphoma</keyword>
	<keyword>noncontiguous stage II marginal zone lymphoma</keyword>
	<keyword>noncontiguous stage II small lymphocytic lymphoma</keyword>
	<keyword>recurrent adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage I adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage II adult T-cell leukemia/lymphoma</keyword>
	<keyword>adult grade III lymphomatoid granulomatosis</keyword>
	<keyword>recurrent adult grade III lymphomatoid granulomatosis</keyword>
	<keyword>adult nasal type extranodal NK/T-cell lymphoma</keyword>
</DOC>